Log In
Print
BCIQ
Print
Print this Print this
 

BI-505

  Manage Alerts
Collapse Summary General Information
Company BioInvent International AB
DescriptionHuman mAb against intercellular adhesion molecule-1 (ICAM-1; CD54)
Molecular Target Intercellular adhesion molecule-1 (ICAM-1) (CD54)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationMultiple myeloma (MM)
Indication DetailsTreat multiple myeloma (MM)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today